Photoradiation in the treatment of recurrent breast carcinoma
- PMID: 283259
Photoradiation in the treatment of recurrent breast carcinoma
Abstract
Photoradiation, with the use of hematoporphyrin derivative (Hpd) activated by visible light in the red region of the spectrum, was an effective treatment for controlling local and regional chest wall recurrences of breast carcinoma. With sufficient time between iv injection of the drug and local activation with red light, cutaneous and subcutaneous masses were treated effectively without undue damage to overlying and adjacent skin. This high therapeutic ratio resulted from the ability to Hpd to accumulate and/or to be retained to a higher degree in malignant tissue than in many normal tissues. This technique can be used as a primary treatment or upon tumor recurrence following conventional modalities such as surgery, chemotherapy, and radiation therapy.
Similar articles
-
Photoradiation therapy for the treatment of malignant tumors.Cancer Res. 1978 Aug;38(8):2628-35. Cancer Res. 1978. PMID: 667856
-
Treatment of mouse carcinomas with intratumoral injections of hematoporphyrin derivative and red light.Photodermatol. 1985 Apr;2(2):107-10. Photodermatol. 1985. PMID: 4034416
-
Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin.Prog Clin Biol Res. 1984;170:829-40. Prog Clin Biol Res. 1984. PMID: 6531372 No abstract available.
-
[Clinical studies on photoradiation therapy with hematoporphyrin derivatives (HpD) and argon dye laser].Nihon Sanka Fujinka Gakkai Zasshi. 1986 May;38(5):693-9. Nihon Sanka Fujinka Gakkai Zasshi. 1986. PMID: 3014026 Japanese.
-
Therapeutic advances: combining photoradiation and laser therapy.Compr Ther. 1990 Apr;16(4):3-8. Compr Ther. 1990. PMID: 2139838 Review. No abstract available.
Cited by
-
Photodynamic therapy for cancer.BMJ. 1992 Mar 7;304(6827):589-90. doi: 10.1136/bmj.304.6827.589. BMJ. 1992. PMID: 1559087 Free PMC article. No abstract available.
-
Neonatal exposure to protoporphyrin-activating lighting as a contributing cause of childhood acute lymphocytic leukemia.Cancer Causes Control. 1992 Jul;3(4):383-7. doi: 10.1007/BF00146893. Cancer Causes Control. 1992. PMID: 1617127
-
Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.Cancer Immunol Immunother. 1988;26(2):125-31. doi: 10.1007/BF00205605. Cancer Immunol Immunother. 1988. PMID: 2965972 Free PMC article.
-
Current use of lasers in pulmonary disease.World J Surg. 1983 Nov;7(6):725-31. doi: 10.1007/BF01655212. World J Surg. 1983. PMID: 6197822 Review. No abstract available.
-
Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo.J Neurooncol. 1994;22(1):7-13. doi: 10.1007/BF01058350. J Neurooncol. 1994. PMID: 7714553
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources